Your browser doesn't support javascript.
loading
Rapid reduction in BCR-ABL1 transcript predicts deep molecular response in dasatinib-treated chronic-phase chronic myeloid leukaemia patients.
Murai, Kazunori; Yamaguchi, Kohei; Ito, Shigeki; Miyagishima, Takuto; Shindo, Motohiro; Wakasa, Kentaro; Inomata, Mitsue; Nagashima, Takahiro; Kondo, Takeshi; Fujimoto, Nozomu; Yamamoto, Satoshi; Yonezumi, Masakatsu; Oyake, Tatsuo; Kowata, Shugo; Tsukushi, Yasuhiko; Mine, Takahiro; Meguro, Kuniaki; Ikeda, Kazuhiko; Watanabe, Reiko; Saito, Souichi; Sato, Shinji; Tajima, Katsushi; Chou, Takaaki; Kubo, Kohmei; Oba, Koji; Sakamoto, Junichi; Ishida, Yoji.
Afiliación
  • Murai K; Division of Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan.
  • Yamaguchi K; Department of Hematology, Iwate Prefectural Central Hospital, Morioka, Japan.
  • Ito S; Department of Hematology, Aomori Prefectural Central Hospital, Aomori, Japan.
  • Miyagishima T; Department of Clinical Oncology, School of Medicine, Iwate Medical University, Morioka, Japan.
  • Shindo M; Department of Internal Medicine, Japan Labour Health and Welfare Organization, Kushiro Rosai Hospital, Kushiro, Japan.
  • Wakasa K; Division of Gastroenterology and Hematology/Oncology, Asahikawa Medical University, Asahikawa, Japan.
  • Inomata M; Division of Hematology, Hokkaido P.W.F.A.C. Obihiro-Kosei General Hospital, Obihiro, Japan.
  • Nagashima T; Division of Hematology, National Hospital Organization Sendai Medical Center, Sendai, Japan.
  • Kondo T; Department of Internal Medicine, Kitami Red Cross Hospital, Kitami, Japan.
  • Fujimoto N; Department of Hematology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Yamamoto S; Division of Hematology, Kaisei Hospital, Sapporo, Japan.
  • Yonezumi M; Department of Hematology, Sapporo City General Hospital, Sapporo, Japan.
  • Oyake T; Department of Hematology, Hokkaido Cancer Center, Sapporo, Japan.
  • Kowata S; Division of Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan.
  • Tsukushi Y; Division of Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan.
  • Mine T; Division of Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan.
  • Meguro K; Division of Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan.
  • Ikeda K; Division of Gastroenterology and Hematology/Oncology, Asahikawa Medical University, Asahikawa, Japan.
  • Watanabe R; Department of Cardiology and Hematology, Fukushima Medical University, Fukushima, Japan.
  • Saito S; Department of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
  • Sato S; Department of Internal Medicine, Nihonkai General Hospital, Sakata, Japan.
  • Tajima K; Department of Hematology, Okitama Public General Hospital, Kawanishimachi Higashi Okitama-gun, Japan.
  • Chou T; Department of Neurology, Hematology, Metabolism, and Diabetology (DNHMED), Yamagata University Faculty of Medicine, Yamagata, Japan.
  • Kubo K; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan.
  • Oba K; Department of Hematology, Aomori Prefectural Central Hospital, Aomori, Japan.
  • Sakamoto J; Department of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Ishida Y; Interfaculty Initiative in Information Studies, The University of Tokyo, Tokyo, Japan.
Eur J Haematol ; 100(1): 27-35, 2018 Jan.
Article en En | MEDLINE | ID: mdl-28895203
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia Mieloide de Fase Crónica / Expresión Génica / Proteínas de Fusión bcr-abl / Inhibidores de Proteínas Quinasas / Dasatinib / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia Mieloide de Fase Crónica / Expresión Génica / Proteínas de Fusión bcr-abl / Inhibidores de Proteínas Quinasas / Dasatinib / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Japón